Filter
4585
Filtered Results: 4585
Text search:
Epidemiology
Featured
Recommendations
402
New Publications
975
Language
Document type
No document type
2375
Studies & Reports
796
Guidelines
736
Manuals
212
Strategic & Response Plan
175
Fact sheets
93
Situation Updates
65
Training Material
59
Resource Platforms
37
Infographics
17
Online Courses
13
Videos
6
Brochures
1
Countries / Regions
Global
194
India
149
Latin America and the Carribbean
138
Western and Central Europe
102
Indonesia
100
Africa
89
Brazil
85
Liberia
76
Nigeria
74
Kenya
72
South Africa
71
Sierra Leone
67
Ethiopia
63
Nepal
60
Eastern Europe
55
Bangladesh
52
Colombia
51
Uganda
49
Paraguay
49
Venezuela
49
Zambia
48
Ukraine
48
Mozambique
46
Russia
46
Philippines
44
Argentina
44
Malawi
42
Tanzania
41
Asia
37
Congo, Democratic Republic of
36
Germany
36
Bolivia
33
Myanmar / Burma
32
Ghana
31
Rwanda
31
Guinea
29
Zimbabwe
29
Senegal
28
South–East Asia Region
28
Syria
27
Chile
27
Middle East and North Africa
27
Peru
24
Ecuador
24
West and Central Africa
22
Angola
21
East and Southern Africa
21
Haiti
18
Burkina Faso
17
Cameroon
17
Cambodia
15
Namibia
15
Lesotho
15
Pakistan
14
Botswana
14
Eastern Europe and Central Asia
14
El Salvador
13
Yemen
12
Western Pacific Region
12
Guinea-Bissau
11
South Sudan
11
Albania
11
Tajikistan
10
Spain
10
USA
9
Benin
9
Madagascar
9
Vietnam
9
Mali
8
Somalia
8
Thailand
8
Eswatini/ Swaziland
8
Côte d’Ivoire / Ivory Coast
7
Afghanistan
7
Sudan
7
Moldova
7
North America
7
Niger
6
Lebanon
6
Jordan
5
China
5
North Macedonia
5
Honduras
5
Sri Lanka
5
Italy
5
Kyrgyzstan
5
Iraq
4
Chad
4
Central African Republic
4
Guatemala
4
Mexico
4
Armenia
4
Iran
4
France
4
Saudi Arabia
3
Turkey
3
Egypt
3
Burundi
3
Southern Africa
3
Kazakhstan
3
Tunisia
3
United Kingdom
3
Portugal
3
Belarus
3
Bosnia and Herzegovina
3
Morocco
2
Togo
2
Gambia
2
Mauritania
2
Dominican Republic
2
Hungary
2
Greece
2
Libya
2
Bhutan
2
Poland
2
Laos
2
Canada
2
Qatar
2
Uzbekistan
2
Uruguay
2
Japan
2
Singapore
1
Papua New Guinea
1
Serbia
1
Croatia
1
Cuba
1
Nicaragua
1
Other region
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Estonia
1
Romania
1
Slovakia
1
Georgia
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Azerbaijan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1645
Clinical Guidelines
432
Public Health
250
Women & Child Health
133
Key Resources
130
Pharmacy & Technologies
53
Capacity Building
51
Toolboxes
COVID-19
558
TB
421
Mental Health
371
HIV
329
Rapid Response
286
NTDs
210
AMR
176
Planetary Health
155
Ebola
137
NCDs
131
Zika
96
Disability
68
Global Health Education
64
Caregiver
63
Pharmacy
50
Polio
44
Conflict
43
Refugee
42
Cholera
37
Natural Hazards
36
Health Financing Toolbox
23
Specific Hazards
15
Typhoon
3
South Sudan
1
Social Ethics
1
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
This Trachoma Action Planning – a planning guide – is published by the
International Coalition for Trachoma Control at the request of the
World Health Organization Alliance for the Global Elimination of Trachoma
by 2020.
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
In 2011, ICTC developed a Trachoma Action Plan (TAP) planning guide to support national health officials in endemic countries. This resource was developed to complement the 2020 INSight roadmap by helping countries create specific national plans detailing how they will reach elimination targets in t...
A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania.
PloS Neglected Tropical Diseases September 30, 2021 https://doi.org/10.1371/journal.pntd.0009789
Schistosoma...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million
people.(1) With such relevant numbers of people affected and disability adjusted life years lost, CD is a poverty-related
and poverty-promoting disease.
Although data describe a relevan...
